Here is a selection of the articles available in issue number 54 of "Thyroid News".
Does every thyroid cancer need treatment?
Professor Leigh Delbridge
There are mixed messages in the media about thyroid cancer. On one hand we hear that thyroid cancer, which up until now, had been considered a rare disorder, has shown a dramatic increase in cases worldwide with a tripling of incidence in the USA. In Australia currently, of all malignancies documented in the national cancer registries, thyroid cancer is the most rapidly increasing in females.
Please note you need to be a member to read these articles in full.
LOGIN TO READ MORE
Name change of active ingredient of Oroxine, Eutroxsig and Eltroxin to align with international terminology.
Aspen Pharma has written to the ATF (letter included in the edition). The name of the active ingredient of Oroxine, Eutroxsig and Eltroxin has been changed in Australia to align with international terminology. Thyroxine will no longer be the name of the active ingredient, it will be now known in Australia as Levo-thyroxine, which is the international reference. Please be aware when speaking to your GP, Endocrinologist or Pharmacist.
Please note you need to be a member to read these articles in full.
LOGIN TO READ MORE